Millions of adults may have LDL (“bad”) cholesterol above the new 2026 treatment targets, increasing the risk of heart disease and highlighting missed opportunities for prevention.
- Researchers found 1 in 3 adults have LDL cholesterol above the new treatment goals
- The 2026 ACC/AHA guidelines recommend lower LDL targets based on heart disease risk
- Early screening and timely treatment can help reduce future heart attacks and strokes
According to Mass General Brigham, researchers publishing in JAMA found that nearly one in three U.S. adults without existing heart disease have LDL, commonly called “bad” cholesterol, above the recommended targets introduced in the 2026 American College of Cardiology (ACC) and American Heart Association (AHA) dyslipidemia guideline (1✔ ✔Trusted Source
Is your cholesterol too high based on latest guidelines?
), (2✔ ✔Trusted Source
Prevalence of LDL-C Above 2026 Dyslipidemia Guideline Goals Among US Adults
).
The analysis also showed that many eligible adults are either not receiving cholesterol-lowering medicines or are not achieving the updated LDL goals despite treatment, highlighting an important opportunity to improve heart disease prevention. The study analyzed health data from approximately 2,300 adults aged 30–79 years who participated in the National Health and Nutrition Examination Survey (NHANES) 2021–2023, representing nearly 178 million U.S. adults. Researchers compared current LDL cholesterol levels with the newly recommended treatment targets to understand how well the population meets the updated cardiovascular prevention goals.
Advertisement
How Well Are Adults Meeting the New LDL Cholesterol Targets?
Researchers from Mass General Brigham applied the 2026 ACC/AHA cholesterol guidelines to data from NHANES 2021–2023 to assess how well adults meet the updated LDL cholesterol goals.
The key findings are summarized below.
Advertisement
Key Findings from the Nationwide JAMA Analysis of Cholesterol Control
|
Study Finding |
Result |
Why It Matters |
|
Study population |
Around 2,300 adults aged 30–79 years from NHANES 2021–2023, representing nearly 178 million U.S. adults |
Provides a nationally representative picture of cholesterol control in the United States. |
|
Adults without previous heart disease |
Nearly 1 in 3 had LDL cholesterol above the updated guideline targets |
Many people at risk of future cardiovascular disease may benefit from earlier intervention. |
|
Untreated adults above LDL target |
About 76% were not receiving any cholesterol-lowering medication |
Indicates a major missed opportunity for preventing heart attacks and strokes before they occur. |
|
Adults with established heart disease |
Nearly 4 in 5 remained above the recommended LDL goal |
Many high-risk patients are still not reaching the stricter cholesterol targets. |
|
Patients already receiving treatment |
Around 62% were taking cholesterol-lowering therapy but had not achieved the new LDL goal |
Suggests that treatment often needs to be intensified rather than simply initiated. |
|
Patients receiving no treatment |
About 38% of adults with existing cardiovascular disease were not on cholesterol-lowering medication |
Highlights an important gap in secondary prevention. |
Advertisement
How Do the New Cholesterol Guidelines Change LDL Treatment Goals?
The 2026 ACC/AHA dyslipidemia guideline places greater emphasis on individual cardiovascular risk rather than using a single LDL cholesterol target for everyone (3✔ ✔Trusted Source
2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
). According to the guideline, people at higher risk of heart attack or stroke should achieve lower LDL cholesterol levels because evidence continues to show that reducing LDL cholesterol lowers future cardiovascular events. The updated recommendations also introduce a new cardiovascular risk calculator to help doctors personalize treatment decisions based on an individual’s overall risk profile.
Before looking at how the U.S. population performed against these recommendations, it is helpful to understand how LDL cholesterol goals differ across cardiovascular risk categories under the updated guideline.
How the 2026 ACC/AHA Cholesterol Guideline Sets LDL Goals According to Cardiovascular Risk
|
Cardiovascular Risk Category |
Recommended LDL Goal / Treatment Threshold |
What It Means |
|
Low cardiovascular risk |
Consider treatment when LDL is 160 mg/dL or higher |
Lifestyle changes remain important, while medicines may be considered depending on overall risk. |
|
Moderate to high cardiovascular risk |
Lower LDL targets than previous recommendations |
Treatment is tailored according to a person’s estimated cardiovascular risk using the updated risk calculator. |
|
Established heart disease with very high cardiovascular risk |
Target below 55 mg/dL |
Intensive cholesterol-lowering therapy is recommended to reduce the risk of future heart attack or stroke. |
|
Overall principle |
Lower LDL is better for higher-risk individuals |
Treatment goals become more aggressive as cardiovascular risk increases. |
Why Are Millions Still Missing Recommended Cholesterol Treatment?
According to Mass General Brigham, the study shows that different groups face different challenges in reaching the new LDL cholesterol goals (4✔ ✔Trusted Source
Study Finds 1 in 3 Americans Without Heart Disease Miss New Cholesterol Goals–and 3 in 4 Go Untreated
).
- Adults Without Heart Disease: Many eligible people are not receiving cholesterol-lowering treatment, missing an opportunity to prevent future heart
disease. - Adults With Heart Disease: Many remain above the recommended LDL target despite treatment and may need more intensive therapy.
- Key Barriers: Limited access to newer medicines, low awareness, and healthcare system challenges continue to hinder cholesterol control.
- Looking Ahead: Since the NHANES 2021–2023 data were collected before the 2026 ACC/AHA guideline, the findings serve as a baseline for
measuring future improvements.
Researchers emphasize that early cholesterol screening, knowing your LDL level, and following personalized treatment goals can help reduce long-term
cardiovascular risk.
Why Should Indians Pay More Attention to High Cholesterol?
The ICMR-INDIAB National Study found that 87.3% of Indian adults have at least one form of dyslipidemia, making abnormal cholesterol levels a major public
health concern in India (5✔ ✔Trusted Source
PREVALENCE OF DYSLIPIDEMIA IN INDIA: THE ICMR-INDIAB NATIONAL STUDY (ICMR-INDIAB–25)
).
Low HDL (“good”) cholesterol was the most common abnormality, and dyslipidemia was more common among urban residents, women, and people with obesity,
diabetes, or hypertension. These findings highlight the need for early cholesterol screening and timely treatment.
Understanding the different components of a lipid profile can help you interpret your cholesterol test results and assess your heart disease risk.
Components of a Lipid Profile and Their Significance
|
Test |
What It Measures |
Why It Matters |
|
LDL (Low-Density Lipoprotein) |
“Bad” cholesterol |
High LDL promotes plaque buildup inside arteries and increases the risk of heart attack and stroke. |
|
HDL (High-Density Lipoprotein) |
“Good” cholesterol |
HDL helps remove excess cholesterol from the bloodstream and protects heart health. |
|
Triglycerides |
Fat circulating in the blood |
High triglycerides, especially when combined with high LDL or low HDL, increase cardiovascular risk. |
|
Total Cholesterol |
Overall cholesterol level |
Used with other lipid values to assess heart disease risk. |
|
Non-HDL Cholesterol |
All harmful cholesterol particles combined |
Provides an overall measure of cholesterol that contributes to artery blockage and is increasingly used in cardiovascular risk assessment. |
When Should You Get Your Cholesterol Checked?
According to the U.S. Centers for Disease Control and Prevention (CDC), high cholesterol usually has no symptoms, so regular screening is the best way to detect it early. Most healthy adults should have their cholesterol checked every 4–6 years, while people at higher risk may need more frequent testing (6✔ ✔Trusted Source
Testing for Cholesterol
). The table below shows the general healthy cholesterol levels for adults (7✔ ✔Trusted Source
Cholesterol Levels
), (8✔ ✔Trusted Source
Diagnosis
).
Healthy Cholesterol Levels for Adults
|
Lipid Measure |
Healthy Level |
|
Total Cholesterol |
Less than 200 mg/dL |
|
LDL (“Bad”) Cholesterol |
Less than 100 mg/dL |
|
HDL (“Good”) Cholesterol – Men |
40 mg/dL or Higher |
|
HDL (“Good”) Cholesterol – Women |
50 mg/dL or Higher |
|
Non-HDL Cholesterol |
Less than 130 mg/dL |
How Can You Keep Your Cholesterol Under Control?
Healthy lifestyle habits play an important role in maintaining healthy cholesterol levels and lowering the risk of heart disease.
Eating a balanced diet that is low in saturated and trans fats while including more fruits, vegetables, whole grains, soluble fiber, and omega-3-rich foods can help improve cholesterol levels.
Regular physical activity, maintaining a healthy weight, avoiding smoking, and limiting alcohol intake also support better heart health.
If cholesterol-lowering medicines are prescribed, they should be taken as directed alongside these healthy lifestyle changes for the best results.
Frequently Asked Questions
Q: Why is LDL called “bad” cholesterol?
A: LDL cholesterol can build up inside artery walls, forming plaques that increase the risk of heart attack and stroke.
Q: Can high cholesterol cause symptoms?
A: Usually no. According to the CDC, high cholesterol is often symptom-free and is detected only through a blood test.
Q: How often should adults check their cholesterol?
A: Most healthy adults should have their cholesterol checked every four to six years, although people at higher cardiovascular risk may need more frequent testing.
Q: Can lifestyle changes reduce high cholesterol?
A: Yes. Eating a heart-healthy diet, exercising regularly, maintaining a healthy weight, and quitting smoking can help improve cholesterol levels.
Q: Why are the new 2026 cholesterol guidelines important?
A: They recommend LDL cholesterol goals based on a person’s cardiovascular risk, allowing earlier and more personalized treatment to reduce future heart disease.
Q: Why is high cholesterol a growing concern in India?
A: The ICMR-INDIAB National Study found that nearly 9 in 10 Indian adults have some form of dyslipidemia, highlighting the need for earlier screening and prevention.
References:
- Is your cholesterol too high based on latest guidelines? – (https://news.harvard.edu/gazette/story/2026/07/is-your-cholesterol-too-high-based-on-latest-guidelines/)
- Prevalence of LDL-C Above 2026 Dyslipidemia Guideline Goals Among US Adults – (https://jamanetwork.com/journals/jama/article-abstract/2851798#)
- 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines – (https://www.ahajournals.org/doi/10.1161/CIR.0000000000001423)
- Study Finds 1 in 3 Americans Without Heart Disease Miss New Cholesterol Goals—and 3 in 4 Go Untreated – (https://www.massgeneralbrigham.org/en/about/newsroom/press-releases/1-in-3-americans-miss-new-cholesterol-goals)
- PREVALENCE OF DYSLIPIDEMIA IN INDIA: THE ICMR–INDIAB NATIONAL STUDY (ICMR-INDIAB–25) – (https://www.sciencedirect.com/science/article/abs/pii/S193328742600440X)
- Testing for Cholesterol – (https://www.cdc.gov/cholesterol/testing/index.html)
- Cholesterol Levels – (https://medlineplus.gov/lab-tests/cholesterol-levels/)
- Diagnosis – (https://www.nhlbi.nih.gov/health/blood-cholesterol/diagnosis)
Source-Medindia